Physician profile
Preston Panicco
NPI 1467803064
$18,264.65
in general payments reported to CMS, 2019-2025
35 companies · $2,120 in 2025
The $2,120 reported for 2025 was more than what 84% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,723 · 2020: $1,828 · 2021: $3,809 · 2022: $3,877 · 2023: $1,531 · 2024: $2,376 · 2025: $2,120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,390 · Travel and Lodging: $2,638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,390.02 |
| Travel and Lodging | $2,637.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medinc of Texas | $3,698.12 | 2021-2023 | |
| Goode Surgical INC | $3,278.58 | 2019-2020 | |
| Stryker Corporation | $2,929.86 | 2019-2025 | N/A, Augment Injectable, Infinity Adaptis |
| Treace Medical Concepts, INC. | $1,628.45 | 2019-2025 | |
| Mission Medical Distribution, LLC | $1,275.06 | 2023-2024 | |
| Arthrex, INC. | $1,111.15 | 2020-2024 | |
| Smith+Nephew, INC. | $785.84 | 2020-2025 | Stravix Pl, Grafix Pl, Grafix |
| Trilliant Surgical LLC. | $614.85 | 2022 | |
| Integra Lifesciences Corporation | $383.74 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kerecis Limited | $311.38 | 2021-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen |
| Organogenesis INC. | $229.12 | 2021-2025 | Puraply, Novachor, Affinity |
| Paratek Pharmaceuticals, INC. | $197.51 | 2021-2025 | Nuzyra |
| Nevro Corp. | $195.35 | 2023 | Senza |
| Depuy Synthes Sales INC. | $193.80 | 2022-2024 | Motoband |
| Coastal Medical Technologies LLC | $171.57 | 2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medshape, INC. | $160.85 | 2022 | |
| Nvision Biomedical Technologies, INC. | $152.94 | 2022-2023 | Foot and Ankle |
| Horizon Therapeutics Plc | $144.81 | 2021-2023 | Krystexxa |
| Abbvie INC. | $141.31 | 2021-2024 | |
| Grt US Holding, INC. | $124.98 | 2020-2022 | |
| Bone Support INC. | $98.62 | 2020 | |
| Melinta Therapeutics, LLC | $79.62 | 2019 | |
| Amgen INC. | $51.83 | 2025 | Krystexxa |
| Kci USA, INC. | $46.28 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $40.67 | 2020 | |
| Medtronic, INC. | $29.94 | 2022 | |
| Biocomposites INC | $29.93 | 2024 | |
| Axogen | $29.78 | 2025 | |
| Mimedx Group, INC. | $22.75 | 2025 | |
| Wright Medical Technology, INC. | $19.93 | 2020 | |
| Ibsa Pharma INC. | $19.19 | 2023 | Tirosint, Licart |
| Dynasplint Systems INC. | $18.90 | 2024 | Dynasplint |
| Bioventus LLC | $17.00 | 2019 | |
| Fidia Pharma USA INC. | $16.83 | 2021 | |
| Solventum Corporation | $14.11 | 2025 | V.A.C. Granufoam, Activ.A.C., V.A.C.Ulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preston Panicco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.